Top in endocrinology: Contaminated sitagliptin; added benefits of bariatric surgery

Although some samples of the antidiabetic drug sitagliptin may contain a human carcinogen called NTTP, the FDA said it hopes to avoid a shortage of the medication by temporarily allowing its distribution.

It was the top story in endocrinology last week.

Another top story was about a new study that showed that bariatric surgery may improve patients’ sex lives — possible due to positive psychological changes, researchers explained.

Read these and more top stories in endocrinology below:

FDA: Possibly contaminated sitagliptin may be distributed to avoid shortage

The FDA announced it has learned that some samples of sitagliptin, used to treat type 2 diabetes, may contain a “nitrosamine impurity,” Nitroso-STG-19 or NTTP, which may be a human carcinogen. Read more.

Bariatric surgery linked to improvements in psychosocial, sex lives for most adults

In a small study, most participants who underwent bariatric surgery experienced positive psychosocial changes and an improved sex life after surgery, according to results published in Bariatric Surgical Practice and Patient Care. Read more.

Hybrid closed-loop therapy offers greater independence for young people with diabetes

Use of a hybrid closed-loop insulin delivery system provided greater independence and flexibility with glycemic management for young people with type 1 diabetes, according to study findings published in Diabetic Medicine. Read more.

Prevalence of undiagnosed diabetes falls during 3-decade period

From 1988 to 2020, cases of undiagnosed diabetes declined markedly, which suggested major improvements in diabetes screening and detection, according to researchers. Read more.

Poor metabolic health parameters linked to low breast milk production

Women with severely low breast milk production have higher BMI, blood pressure and plasma lipid levels compared with those with normal milk production, according to a study published in Breastfeeding Medicine. Read more.